Faculty of Medicine and Healthcare of the Al-Farabi Kazakh National University, Almaty, expresses you deep respect and invites you to take part in the II International Conference "Respiratory Junction Almaty: Where East meets West" at April 3-4 2020 in al-Frabi University.
The conference will bring together well-known scientists from the leading universities in the USA, Great Britain, Russia, and Kyrgyzstan; heads of research organizations and state bodies of Kazakhstan, representatives of state and commercial organizations of education and health.
The goal of the Conference is regular knowledge exchange between the leading pulmonary experts of the East and the West. The mission of our Conference is the shift of standards of pulmonary care through dialogue and knowledge transfer on the latest advances in the diagnosis and treatment trough the globe.
Topic of 2020 – “Hereditary and rare diseases of the lung”, the relevance of which is due to the complexity of their diagnosis and treatment. Hereditary lung diseases is a great medical and social burden for society, its role in the structure of severe pathology and mortality is quite large.
We are pleased to announce that the key speaker at the International Conference “Respiratory Junction Almaty: Where East meets West” 2020 will be one of the world's leading experts: Larry C. Lands, MD, PhD; Director, Pediatric Respiratory Medicine, Pediatric Cystic Fibrosis Clinic, and Pediatric Pulmonary Function Laboratory Montreal, Quebec (Canada); Professor Sarah H Elsea, Molecular and Human Genetics, Senior Director, Biochemical, Baylor Genetics. Baylor College of Medicine (US); Daryl Armstrong Scott, M.D., Ph.D., Associate Professor Molecular and Human Genetics Baylor College of Medicine (US); Pediatric Clinical Geneticist, Texas Children’s Hospital; Oleg Shchelochkov, M.D. Fellow of the American Academy of Pediatrics, Diplomate of the American Board of Medical Genetics (Clinical Genetics and Medical Biochemical Genetics), Associate Physician Investigator, National Human Genome Research Institute (US); Ghazwan Butrous MB, ChB PhD FESC FRSA, Prof. Cardiopulmonary Science University of Kent, Canterbury, UK.
Within the framework of the International Conference, plenary and breakout sessions are scheduled, workshop for biomedical technologies with participation of professor Bazbek Davletov, Department of Biomedical Science The University of Sheffield.
The round table with the participation of public organizations that are involved in helping patients with bronchopulmonary pathology have planned.
The venue of conference: Almaty, Al-Farabi Ave. 71, al-Farabi Kazakh National University, the University Library.